Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancers Journal Article


Authors: Veeraraghavan, H.; Friedman, C. F.; DeLair, D. F.; Ninčević, J.; Himoto, Y.; Bruni, S. G.; Cappello, G.; Petkovska, I.; Nougaret, S.; Nikolovski, I.; Zehir, A.; Abu-Rustum, N. R.; Aghajanian, C.; Zamarin, D.; Cadoo, K. A.; Diaz, L. A. Jr; Leitao, M. M. Jr; Makker, V.; Soslow, R. A.; Mueller, J. J.; Weigelt, B.; Lakhman, Y.
Article Title: Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancers
Abstract: To evaluate whether radiomic features from contrast-enhanced computed tomography (CE-CT) can identify DNA mismatch repair deficient (MMR-D) and/or tumor mutational burden-high (TMB-H) endometrial cancers (ECs). Patients who underwent targeted massively parallel sequencing of primary ECs between 2014 and 2018 and preoperative CE-CT were included (n = 150). Molecular subtypes of EC were assigned using DNA polymerase epsilon (POLE) hotspot mutations and immunohistochemistry-based p53 and MMR protein expression. TMB was derived from sequencing, with > 15.5 mutations-per-megabase as a cut-point to define TMB-H tumors. After radiomic feature extraction and selection, radiomic features and clinical variables were processed with the recursive feature elimination random forest classifier. Classification models constructed using the training dataset (n = 105) were then validated on the holdout test dataset (n = 45). Integrated radiomic-clinical classification distinguished MMR-D from copy number (CN)-low-like and CN-high-like ECs with an area under the receiver operating characteristic curve (AUROC) of 0.78 (95% CI 0.58–0.91). The model further differentiated TMB-H from TMB-low (TMB-L) tumors with an AUROC of 0.87 (95% CI 0.73–0.95). Peritumoral-rim radiomic features were most relevant to both classifications (p ≤ 0.044). Radiomic analysis achieved moderate accuracy in identifying MMR-D and TMB-H ECs directly from CE-CT. Radiomics may provide an adjunct tool to molecular profiling, especially given its potential advantage in the setting of intratumor heterogeneity. © 2020, The Author(s).
Journal Title: Scientific Reports
Volume: 10
ISSN: 2045-2322
Publisher: Nature Publishing Group  
Date Published: 2020-10-20
Start Page: 17769
Language: English
DOI: 10.1038/s41598-020-72475-9
PUBMED: 33082371
PROVIDER: scopus
PMCID: PMC7575573
DOI/URL:
Notes: Article -- Export Date: 2 November 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Vicky Makker
    263 Makker
  2. Yuliya Lakhman
    95 Lakhman
  3. Mario Leitao
    575 Leitao
  4. Dmitriy Zamarin
    201 Zamarin
  5. Robert Soslow
    793 Soslow
  6. Ahmet Zehir
    343 Zehir
  7. Deborah F DeLair
    106 DeLair
  8. Karen Anne Cadoo
    113 Cadoo
  9. Britta Weigelt
    632 Weigelt
  10. Jennifer Jean Mueller
    186 Mueller
  11. Claire Frances Friedman
    117 Friedman
  12. Yuki   Himoto
    4 Himoto
  13. Luis Alberto Diaz
    148 Diaz
  14. Silvio Giancarlo Bruni
    1 Bruni